FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ stock dips on earnings
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
Healthline7d
Migraine Nasal Sprays Explained
They can help you find out if a nasal spray may be beneficial for your acute migraine symptoms. They can also inform you of any side effects or interactions to watch out for. Healthline has strict ...
The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
Cure Today8d
PH284 Nasal Spray May Improve Feelings of Hunger in Cancer Cachexia
PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.